DSGN (STOCKS)
Design Therapeutics, Inc. Common Stock
$10.360000
+0.130000 (+1.27%)
Prev close: $10.230000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Pratik Shah
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $588.44M
- Employees
- 55
- P/E (TTM)
- -8.73
- P/B (TTM)
- 2.92
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $77.99M |
| Research and Development | $57.86M |
| Other Operating Expenses | $20.13M |
| Operating Income/Loss | -$77.99M |
| Income/Loss From Continuing Operations After Tax | -$67.45M |
| Income/Loss From Continuing Operations Before Tax | -$67.45M |
| Net Income/Loss | -$67.45M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$67.45M |
| Net Income/Loss Available To Common Stockholders, Basic | -$67.45M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.19 |
| Diluted Earnings Per Share | -$1.19 |
| Basic Average Shares | 113,791,717 |
| Diluted Average Shares | 113,791,717 |
| Assets | $211.77M |
| Current Assets | $209.03M |
| Cash | $206.00M |
| Prepaid Expenses | $1.68M |
| Other Current Assets | $1.35M |
| Noncurrent Assets | $2.74M |
| Fixed Assets | $1.10M |
| Other Non-current Assets | $1.64M |
| Liabilities | $12.05M |
| Current Liabilities | $11.17M |
| Accounts Payable | $1.91M |
| Wages | $3.47M |
| Other Current Liabilities | $5.79M |
| Noncurrent Liabilities | $877.00K |
| Equity | $199.72M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $199.72M |
| Liabilities And Equity | $211.77M |
| Net Cash Flow From Operating Activities | -$52.25M |
| Net Cash Flow From Operating Activities, Continuing | -$52.25M |
| Net Cash Flow From Investing Activities | $36.33M |
| Net Cash Flow From Investing Activities, Continuing | $36.33M |
| Net Cash Flow From Financing Activities | $684.00K |
| Net Cash Flow From Financing Activities, Continuing | $684.00K |
| Net Cash Flow | -$15.24M |
| Net Cash Flow, Continuing | -$15.24M |
| Comprehensive Income/Loss | -$68.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$68.00M |
| Other Comprehensive Income/Loss | -$17.55M |